Health Minister’s low, single exit-price increase disappoints industry
Health Minister Aaron Motsoaledi has gazetted an increase in the single exit price for medicines and scheduled substances, which the pharmaceutical industry says is "pitifully low" and will have a devastating impact on small manufacturers, in particular. The Pharmaceutical Task Group, which represents all the formalised trade associations and covers about 95% of the market, plans to take up the 1.26% increase announced last week with the minister in a bid for him to use his discretion to decide on an increase that is higher than that generated by the formula used. Aspen Pharmaceutical senior executive Stavros Nicolaou said that while the industry agreed that the increase was based on the formula, the minister had discretion to make decisions outside of it. In the long term, the industry wants to have the formula restructured so it adequately reflected market forces. "In the past, the formula has only been used as a guide. The minister does have the discretion to operate outside of i...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.